These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9272245

  • 1. Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Thebault JJ, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1997 Jul; 47(7):859-65. PubMed ID: 9272245
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 3. Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.
    Setnikar I, Rovati LC, Santoro A, Guillaume M, Mignot A, Renoux A, Gualano V.
    Arzneimittelforschung; 1999 Aug; 49(8):708-15. PubMed ID: 10483519
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [Abstract] [Full Text] [Related]

  • 5. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD, Ehrly AM, Kuhl H.
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA, Zegarac EA, Eldon MA, Sedman AJ, Forgue ST.
    Biopharm Drug Dispos; 1996 Aug; 17(6):459-70. PubMed ID: 8866037
    [Abstract] [Full Text] [Related]

  • 7. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL, Gattermeir DJ, Petersen CA, Day WW, Schumacher RJ.
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [Abstract] [Full Text] [Related]

  • 8. Bioavailability of estradiol from two transdermal patches.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Mar; 46(3):307-10. PubMed ID: 8901155
    [Abstract] [Full Text] [Related]

  • 9. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
    Schmolling J, Kusche J, van der Ven H, Schander K.
    Zentralbl Gynakol; 1998 Mar; 120(3):121-5. PubMed ID: 9556902
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H, Koytchev R, Mayer O, Börner A, Mellinger U, Breitbarth H.
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [Abstract] [Full Text] [Related]

  • 11. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
    Buch A, Shen L, Kelly S, Sahota R, Brezovic C, Bixler C, Powell J.
    Menopause; 1998 Sep; 5(2):107-12. PubMed ID: 9689205
    [Abstract] [Full Text] [Related]

  • 12. Plasma levels of glyceryl trinitrate and dinitrates during application of three strengths of a new glyceryl trinitrate transdermal patch.
    Santoro A, Rovati LC, Follet M, Setnikar I, Caplain H, Gualano V.
    Arzneimittelforschung; 2000 Sep; 50(9):786-94. PubMed ID: 11050694
    [Abstract] [Full Text] [Related]

  • 13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 14. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD, Nauert C, Stehle B.
    Maturitas; 1999 Sep 24; 33(1):45-58. PubMed ID: 10585173
    [Abstract] [Full Text] [Related]

  • 15. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: experimental results.
    Rohr UD, Saeger-Lorenz K.
    J Pharm Sci; 2002 Mar 24; 91(3):810-21. PubMed ID: 11920767
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estrone.
    Boyd RA, Yang BB, Abel RB, Eldon MA, Sedman AJ, Forgue ST.
    J Clin Pharmacol; 1996 Nov 24; 36(11):998-1005. PubMed ID: 8973988
    [Abstract] [Full Text] [Related]

  • 17. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug 24; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 18. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 19. Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion.
    Taylor MB, Gutierrez MJ.
    Pharmacotherapy; 2008 Jun 20; 28(6):712-8. PubMed ID: 18503399
    [Abstract] [Full Text] [Related]

  • 20. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 20; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.